Conventional anti-dementia treatment group

DRUG3 trials

Sponsors

Cuibai Wei，Clinical Professor, Second Affiliated Hospital, School of Medicine, Zhejiang University, First Affiliated Hospital of Wenzhou Medical University

Conditions

Alzheimer DementiaAlzheimer Dementia (AD)Alzheimer Disease (AD)Alzheimer s DiseaseAlzheimer's DiseaseFunctional Magnetic Resonance ImagingLecanemabMCI-AD, Early Stage Alzheimer's Disease

Phase 4

Evaluating the Efficacy and Safety of Lecanemab in Alzheimer's Disease Through Multi-omics Approachs

RecruitingNCT07604896

First Affiliated Hospital of Wenzhou Medical UniversityAlzheimer Dementia (AD), Alzheimer s Disease, MCI-AD, Early Stage Alzheimer's Disease

Start: 2026-01-01End: 2028-12-31Target: 200Updated: 2026-05-22

Unknown Phase

The Clinical Study of Synaptic Plasticity-based Lencanumab for the Treatment of Early Alzheimer's Disease

RecruitingNCT06871839

Cuibai Wei，Clinical ProfessorAlzheimer's Disease, Functional Magnetic Resonance Imaging, Lecanemab

Start: 2025-03-10End: 2026-12-31Target: 120Updated: 2025-07-22

Therapeutic Efficacy of Monoclonal Antibody Drugs for Alzheimer's Disease Based on PET Research

Not yet recruitingNCT07152418

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityAlzheimer Dementia, Alzheimer Disease (AD), Mild Cognitive Impairment (MCI)

Start: 2025-09-01End: 2028-09-01Target: 120Updated: 2025-09-03